BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: v-myc myelocytomatosis viral oncogene homolog (MYC; c-Myc); ATM interactor (ATMIN); dynein light chain LC8-type 1 (DYNLL1)

February 4, 2016 8:00 AM UTC

Mouse studies suggest inhibiting ATMIN or DYNLL1 could help treat MYC-driven B cell lymphoma. In a mouse model of MYC-driven B cell lymphoma, knockout of ATM decreased tumor growth, the number of B ce...